CellDMC achieved over 60% sensitivity to detect the gold standard list, compared to effectively zero sensitivity when the breast cancer labels were randomized, clearly demonstrating that the identified epithelial DMCTs are bona fide TN-ER+ DMCTs (Fig. 5e). This evidence concerns the gene ESR1 and breast cancer.